Aytu Bioscience announces first sales for male infertility system

Aytu Bioscience announces first sales for male infertility system

ENGLEWOOD -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the first... Read More

Tuesday February 9, 2016 0 comments Tags: Aytu BioScience, Josh Disbrow, Englewood, MiOXSYS, male infertility